Results 11 to 20 of about 73,649 (308)

Nasopharyngeal Myoepithelial Carcinoma Mimicking Nasopharyngeal Carcinoma

open access: yesJournal of Cancer Research and Practice, 2015
AbstractMyoepithelial carcinoma (malignant myoepithelioma) (MC) is a rare tumor, defined as a malignant salivary neoplasm composed almost exclusively of tumor cells with myoepithelial differentiation. It can arise in unusual location sites, such as the nasopharynx, and may be difficult to approach.
Chieh-Sheng Lu   +5 more
openaire   +3 more sources

A global view of the oncogenic landscape in nasopharyngeal carcinoma : an integrated analysis at the genetic and expression levels [PDF]

open access: yes, 2012
Previous studies have reported that the tumour cells of nasopharyngeal carcinoma (NPC) exhibit recurrent chromosome abnormalities. These genetic changes are broadly assumed to lead to changes in gene expression which are important for the pathogenesis of
Aicha Amari   +78 more
core   +1 more source

Membranous Nephropathy Complicating Nasopharyngeal Carcinoma [PDF]

open access: yes, 2010
The patient was a 38-year-old woman diagnosed with nephrotic syndrome. Steroid pulse therapy and mizoribine was started in late October 2002 and continued for about 10 months, but no apparent therapeutic effect was obtained.
Furusu, Akira   +17 more
core   +1 more source

Nasopharyngeal carcinoma in Uganda [PDF]

open access: yesCancer, 1972
Review of histologic material seen in Uganda over the 5-year period, 1964–1968, revealed 83 cases of nasopharyngeal carcinoma out of a total of 7,000 malignant tumors. All tumors conformed to the anaplastic type, but those with a small cell structure occurred in older men than those made up of larger cells. The histologic appearances of this tumor were
R, Schmauz, A C, Templeton
openaire   +2 more sources

Short‐term efficacy and long‐term survival of nasopharyngeal carcinoma patients with radiographically visible residual disease following observation or additional intervention: A real‐world study in China

open access: yesLaryngoscope Investigative Otolaryngology, 2022
Background To explore the short‐ and long‐term outcomes in patients with nasopharyngeal carcinoma (NPC) with magnetic resonance imaging (MRI)‐detected residual disease at 3 months post‐treatment who received intervention either promptly (0 month) or ...
Ying‐Ying Huang   +5 more
doaj   +1 more source

The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling

open access: yesJournal of Experimental & Clinical Cancer Research, 2018
Background Distant metastasis is the major cause of treatment failure in patients with nasopharyngeal carcinoma (NPC). Although several biomarkers correlate with metastasis and prognosis, the molecular mechanisms of NPC development and progression remain
Wen-Ze Qiu   +13 more
doaj   +1 more source

Spatial heterogeneity of immune infiltration predicts the prognosis of nasopharyngeal carcinoma patients

open access: yesOncoImmunology, 2021
Spatial information on the tumor immune microenvironment is of clinical relevance. Here, we aimed to quantify the spatial heterogeneity of lymphocytes and cancer cells and evaluated its prognostic value in patients with nasopharyngeal carcinoma (NPC ...
Ya-Qin Wang   +14 more
doaj   +1 more source

Incidence, consequences, and predictors of serious chemotherapy‐induced thrombocytopenia in nasopharyngeal carcinoma

open access: yesCancer Medicine, 2023
Objectives This study aimed to investigate the incidence, consequences, and predictors of serious chemotherapy‐induced thrombocytopenia (CIT) in nasopharyngeal carcinoma (NPC).
Lu‐Lu Zhang   +11 more
doaj   +1 more source

Adding Concurrent Chemotherapy Significantly Improves the Survival of Stage II-IVb Nasopharyngeal Carcinoma Patients Treated With Concurrent Anti-EGFR Agents

open access: yesFrontiers in Oncology, 2021
ObjectiveAnti-EGFR Targeted agents were found to be capable of modulating the antitumor immunity in head and neck cancer and become more and more frequently used in the treatment of nasopharyngeal carcinoma(NPC).
Zi-Kun Yu   +11 more
doaj   +1 more source

Increasing Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients [PDF]

open access: yes, 2020
Nasopharyngeal carcinoma (NPC) has radiosensitive and chemosensitive properties. The lack of radiotherapy devices makes concurrent chemoradiation difficult in Indonesia.
Muhtarum Yusuf, -, Andri Foris, -
core   +1 more source

Home - About - Disclaimer - Privacy